Triomab® Applications: Trion Pharma

l Pioneers
l Triomab® Format
l Triomab® Mode of Action
l Triomab® Applications
l Triomab® Advantages
l Scientific Publications

Deutsch

Send email

June 06, 2011

Trifunctional Antibody Catumaxomab Triggers Vaccination Effect Against Cancer

Key information on Triomab®
undefined Triomab® backgrounder

Triomab® Applications

Triomab® is a powerful product development platform: By exchanging the tumor-specific arm, trifunctional antibodies can easily be tailored to various indications.

So far, Triomab antibodies® have been generated against EpCAM, HER2 and CD20. Using the Triomab® technology, any traditional antibody on the market could be transformed into a trifunctional format with improved anti-tumor efficacy against tumor cells.